ARCHIVES

Contract Authority Expiration Confuses NCI Money Bill Estimates, Which Range From $605 To $650 Million

This article is from The Cancer Letter archive.

Vol. 01 No. 20 | June 21, 1974

Download PDF Visit The Full Archive

Related Articles

St. John’s Wort Not Indicated For Patients On Irinotecan

May 31, 2002

In Brief: Surgeons Oncology Group Gets NCI Funding To Conduct Multicenter Clinical Trials

April 17, 1998

“Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor

November 8, 2013

Also Kevin Cullen named director, Univ. of Maryland Greenebaum Cancer Center.

November 28, 2003

Arnold Brown Will Be Appointed NCI Director; Rauscher, Staff “Couldn’t Be More Pleased”

October 22, 1976

NCI-Approved Clinical Trials

February 23, 2007